Super proud of my PhD student's first paper published in @psychopharmacology.bsky.social We found dysfunction stress response to social rejection of the #endocannabinoid 2-AG in individuals with chronic #opioid use #OUD
Check it out:
rdcu.be/eOkoh
Please RT
2 new positions in the lab as postdoc & PhD!
Interested in stress, pain, or reward? This project has it all!
We are a friendly but ambitious group. Oslo is a capital city on the fjord & bordered by forest, great urban & outdoors opportunities: 💃 ⛷️ 🚣 🎭 🎶
www.jobbnorge.no/en/available...
Merci 😊
Super excited to be elected as a new Full Committee member of @eurbehavpharm.bsky.social happy to be part of the society and looking forward to contribute to it within the next few years! 🤩
What a perfect ending of #EBPS2025 super proud that I was the chair of this wonderful panel presenting their beautiful work on acute and chronic #cannabis effects. Excellent work @connorhaggarty.bsky.social @zivacooper.bsky.social Amir Englund & Lukas Eggeneberger 🤩
Had the immense pleasure of presenting our recent PE+THC clinical trial data today at #EBPS2025. Thanks to @krollsara.bsky.social for the invite. I was in good company with Lukas Eggenberger, @zivacooper.bsky.social and Amir Englund
Parallel Session 8 features this first symposium chaired by @krollsara.bsky.social exploring the positive and negative impact of cannabinoids from sex-differences to pharmacotherapeutic applications #EBPS2025 #Cannabinerds
Welcome!
The mission of the @s4sn.bsky.social is to serve as an international, interdisciplinary, distributed gathering place to advance and foster scientific training, research, and applications in the field for the sake of humankind. 🧠
Find more info here: www.s4sn.org
